“Bevacizumab in Combination with FOLFIRI in the First-Line Treatment of Patients with Advanced Colorectal Cancer: A Single-Institution Experience” (2014) Journal of Analytical Oncology, 3(1), pp.  26–32. doi:10.6000/1927-7229.2014.03.01.4.